BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28930804)

  • 1. Venous Thromboembolism in Gynecological Malignancy.
    Cohen A; Lim CS; Davies AH
    Int J Gynecol Cancer; 2017 Nov; 27(9):1970-1978. PubMed ID: 28930804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
    Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
    Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study.
    Murofushi KN; Tomita T; Ohnishi K; Nakai K; Akiyama A; Saida T; Okumura T; Karasawa K; Satoh T; Sakurai H
    Radiat Oncol; 2021 Jun; 16(1):121. PubMed ID: 34187506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience.
    Morimoto A; Ueda Y; Yokoi T; Tokizawa Y; Yoshino K; Fujita M; Kimura T; Kobayashi E; Matsuzaki S; Egawa-Takata T; Sawada K; Tsutsui T; Kimura T
    Anticancer Res; 2014 Jul; 34(7):3589-95. PubMed ID: 24982374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a venous thromboembolism risk assessment model in gynecologic oncology.
    Stroud W; Whitworth JM; Miklic M; Schneider KE; Finan MA; Scalici J; Reed E; Bazzett-Matabele L; Straughn JM; Rocconi RP
    Gynecol Oncol; 2014 Jul; 134(1):160-3. PubMed ID: 24796634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous thromboembolism.
    Wells PS; Forgie MA; Rodger MA
    JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
    Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors.
    Muntz JE; Michota FA
    Am J Surg; 2010 Jan; 199(1 Suppl):S11-20. PubMed ID: 20103080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
    Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
    Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
    Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
    J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.
    Fanola CL
    Vasc Health Risk Manag; 2015; 11():271-82. PubMed ID: 26064057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and Venous Thromboembolic Disease: A Review.
    Donnellan E; Khorana AA
    Oncologist; 2017 Feb; 22(2):199-207. PubMed ID: 28174293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism: a clinical review.
    Osinbowale O; Ali L; Chi YW
    Postgrad Med; 2010 Mar; 122(2):54-65. PubMed ID: 20203456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism syndrome in gynecological cancer.
    Wang X; Fu S; Freedman RS; Kavanagh JJ
    Int J Gynecol Cancer; 2006; 16 Suppl 1():458-71. PubMed ID: 16515646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Ma SG; Hu J; Huang Y
    Thromb Res; 2020 Dec; 196():325-334. PubMed ID: 32977132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.
    Satoh T; Matsumoto K; Tanaka YO; Akiyama A; Nakao S; Sakurai M; Ochi H; Onuki M; Minaguchi T; Sakurai H; Yoshikawa H
    Thromb Res; 2013 Apr; 131(4):e127-32. PubMed ID: 23433998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.